Overview

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Status:
Completed

Trial end date:
2018-11-30

Target enrollment:

Participant gender:

Summary

This is a phase III, multi-center, randomized, active-comparator, study in subjects with ABSSSI. The study has two subgroups for assessment of efficacy and safety - oral subgroup 1 and IV subgroup 2. Each subgroup will comprise of two treatment arms.

Phase:

Phase 3

Details

Lead Sponsor:

Wockhardt

Treatments:

Levonadifloxacin
Linezolid